Clinical Trials on Cytomegalovirus-Infektionen

Total 424 results

University of North Carolina, Chapel Hill

Completed

Effect of Burn Size on Cytomegalovirus Reactivation and Correlates of T Cell Immune Function in Burned Patients

Burns | Cytomegalovirus

United States
Anhui Provincial Hospital

Recruiting

Effect of Letermovir Prophylaxis on CMV-specific Immune Reconstitution Post UCBT

Cytomegalovirus Infection Reactivation

China
National Institute of Allergy and Infectious Diseases...

Active, not recruiting

Dried Blood Spot Testing of CMV Detection in HCT Recipients

Cytomegalovirus Infection

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Healthy Volunteers With or Without Previous Exposure to Cytomegalovirus

Cytomegalovirus Infection | Healthy, no Evidence of Disease

United States
Maimónides Biomedical Research Institute of Córdoba
MERCK SHARP & DOHME DE ESPAÑA S.A.

Not yet recruiting

Efficacy of Letermovir in Preventing Cytomegalovirus (CMV) Infection in Lung Transplant Recipients vs. Valganciclovir. (LETERCOR)

Infections, Cytomegalovirus

Spain
Merck Sharp & Dohme LLC

Completed

A Study of Letermovir (MK-8228) to Evaluate Efficacy and Safety for Prevention of CMV Infection in Chinese Hematopoietic Stem Cell Transplant Recipients (MK-8228-045)

Cytomegalovirus Infection

China
Chimerix

Completed

Study of CMX001 to Prevent/Control Cytomegalovirus Infection in R+ Hematopoietic Stem Cell Transplant Recipients

Cytomegalovirus Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

Short-Term vs. Long-Term Valganciclovir Therapy for Symptomatic Congenital CMV Infections

Cytomegalovirus Infection

United Kingdom, United States
National Institute of Allergy and Infectious Diseases...

Completed

Comparison of Two Test Methods-NASBA and Antigenemia-for Detecting Cytomegalovirus Infection

Infection | Cytomegalovirus Infection

United States
Helio Tedesco Silva Junior
Sanofi; Novartis

Completed

Comparison Between Two Tacrolimus-based Immunosuppressant Regimens and Induction With Thymoglobulin in Kidney Transplants From Deceased Donors With Expanded Criteria

Kidney Transplantation | Cytomegalovirus

Brazil
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Letermovir-based Dual Therapy for Treatment of Cytomegalovirus Infections (LUCY-1)

Cytomegalovirus Infection

France
GlaxoSmithKline

Completed

Study of the Transmission of Cytomegalovirus (CMV) Infection From Mother to Foetus

Cytomegalovirus Infections | Infections, Cytomegalovirus

Belgium
University of Alberta

Completed

Quantiferon - Cytomegalovirus (CMV) and the Prediction of CMV Infection In High Risk Solid Organ Transplant Recipients

Cytomegalovirus Infection

Canada
IRCCS Policlinico S. Matteo

Completed

Efficacy Study of Human Cytomegalovirus (HCMV) Hyperimmune Globulin to Prevent Congenital HCMV Infection (CHIP)

Cytomegalovirus Infection

Italy
Hospital do Rim e Hipertensão

Completed

Efficacy and Safety of Induction Strategies Combined With Low Tacrolimus Exposure in Kidney Transplant Recipients Receiving Everolimus or Sodium Mycophenolate

Cytomegalovirus Infection | Transplant; Complication, Rejection | Renal Transplant Failure

Brazil
Fondazione Onlus Camillo De Lellis
Regione Abruzzo, Italy; Azienda Sanitaria Locale di Pescara

Unknown

Evaluation of the Safety and Efficacy of Standard Intravenous Immunoglobulins in Pregnant Women With Primary Cytomegalovirus Infection

Cytomegalovirus Congenital Infection

Italy
GlaxoSmithKline

Completed

A Study in Adolescent Females to Explore Cytomegalovirus Infection

Infections, Cytomegalovirus

Finland, United States, Mexico
University Hospital, Limoges

Terminated

Assessing the Risk of CMV Infection of the Renal Transplant About R + by Cellular Immunity Analyzed by the QuantiFERON ®-CMV Test. (QUANTIC-R+)

Renal Transplant Recipient | Immunized Against the Cytomegalovirus

France
Southern Illinois University
University of Alabama at Birmingham

Completed

Screening for Congenital Cytomegalovirus Infection in Newborns (CMV)

Cytomegalovirus Infections
Salvador Gil-Vernet
Roche Pharma AG

Completed

Valganciclovir for Treatment of Cytomegalovirus Infection in Solid Organ Transplant Patients

Cytomegalovirus Infection

Spain
New York Medical College
Merck Sharp & Dohme LLC

Completed

Cytomegalovirus (CMV) Viremia and Disease Occurrence in Pediatric Allogeneic Stem Cell Transplantation Recipients

Cytomegalovirus Infections

United States
M.D. Anderson Cancer Center
Miltenyi Biotec B.V. & Co. KG

Completed

Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Cytomegalovirus (CMV) Reactivation

Lymphoma | Leukemia

United States
Yae-Jean Kim
Miltenyi Biotec B.V. & Co. KG

Withdrawn

Adoptive Transfer of pp65-specific T Cells for the Treatment of Refractory Cytomegalovirus (CMV) Infection

Cytomegalovirus Infections

Korea, Republic of
Dr. Ann C.T.M. Vossen
Leiden University Medical Center; Stichting Nuts Ohra

Completed

Congenital Cytomegalovirus: Efficacy of Antiviral Treatment (CONCERT 2)

Sensorineural Hearing Loss | Congenital Cytomegalovirus Infection

Netherlands
Assistance Publique - Hôpitaux de Paris

Completed

Prenatal Treatment of Congenital Cytomegalovirus Infection With Letermovir Randomized Against Valaciclovir - STEP 1 (CYMEVAL3-STEP1) (CYMEVAL3-STEP1)

Pregnant Women Undergoing TOP | TOP - Failed Attempted Termination of Pregnancy

France
Memorial Sloan Kettering Cancer Center
Atara Biotherapeutics

Completed

Primary Transplant Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation

Cytomegalovirus

United States
Lower Saxony Center for Nephrology

Completed

Prophylaxis With Ganciclovir Improves Graft Survival in Renal Allograft Recipients

Herpesviridae Infections | Cytomegalovirus Infection | DNA Virus Infection
Dr. Ann C.T.M. Vossen
Leiden University Medical Center; Stichting Nuts Ohra

Terminated

Congenital Cytomegalovirus: Efficacy of Antiviral Treatment in a Randomized Controlled Trial (CONCERT)

Sensorineural Hearing Loss | Congenital Cytomegalovirus Infection

Netherlands
University Hospital, Bordeaux
Novartis

Completed

Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporine Versus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine A (EVERCMV)

Transplantation Infection | Cytomegalovirus Infection

France
University Health Network, Toronto
Canadian National Transplant Research Program

Completed

Cell-Mediated Immunity Based Primary Prophylaxis for CMV Infection in Organ Transplant Recipients (QFT-CMV)

Cytomegalovirus Viraemia

Spain, Canada
Assistance Publique - Hôpitaux de Paris

Recruiting

Biomarkers of Cytomegalovirus Fetal Infection and Disease (BIO-CCMV)

Cytomegalovirus Congenital

France
Baylor College of Medicine
The Methodist Hospital Research Institute; Center for Cell and Gene Therapy...

Completed

Safety, Toxicity and MTD of One Intravenous IV Injection of Donor CTLs Specific for CMV and Adenovirus (ACT-CAT)

Cytomegalovirus Infection | Adenovirus Infection

United States
Tianjin Medical University

Recruiting

Clinical Study of High Concentration Ganciclovir Eye Drops in the Treatment of Cytomegalovirus Retinitis

Cytomegalovirus Retinitis | Ganciclovir Eye Drops

China
Helio Tedesco Silva Junior

Completed

Natural History of Cytomegalovirus (CMV) Infection and Disease Among Renal Transplant Recipients

Infection in Solid Organ Transplant Recipients

Brazil
St. Anna Kinderkrebsforschung

Withdrawn

Virus-specific ImmunoTherapy Following Allogeneic Stem Cell Transplantation (VISIT)

Cytomegalovirus Infection | Adenovirus Infection

Austria
Fondation Ophtalmologique Adolphe de Rothschild

Recruiting

Prevalence of Endolymphatic Hydrops With a Hitory of Congenital Cytomegalovirus Infection (HYDROPS-CMV)

Endolymphatic Hydrops

France
National Institute of Allergy and Infectious Diseases...
Hoffmann-La Roche; Schering-Plough

Completed

The Safety and Effectiveness of Ganciclovir Used Alone or in Combination With Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus (CMV) of the Eye in Patients With AIDS

HIV Infections | Cytomegalovirus Retinitis

United States
National Institute of Allergy and Infectious Diseases...

Completed

Suppression of Cytomegalovirus Retinitis Utilizing High Dose Intravenous Acyclovir and Oral Zidovudine in Patients With AIDS

HIV Infections | Cytomegalovirus Retinitis

United States
National Institute of Allergy and Infectious Diseases...
Facet Biotech

Completed

Comparison of Two Methods in the Treatment of Cytomegalovirus of the Eyes in Patients With AIDS

HIV Infections | Cytomegalovirus Retinitis

United States
Johns Hopkins Bloomberg School of Public Health

Completed

Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT) (GCCRT)

HIV Infections | Cytomegalovirus Retinitis

United States
Johns Hopkins Bloomberg School of Public Health

Completed

Studies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis Trial (MACRT) (MACRT)

HIV Infections | Cytomegalovirus Retinitis
National Institute of Allergy and Infectious Diseases...
Hoffmann-La Roche

Completed

A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Peripheral Cytomegalovirus Retinitis in Patients With AIDS

HIV Infections | Cytomegalovirus Retinitis

United States
National Institute of Allergy and Infectious Diseases...

Completed

Comparison of Two Drugs, Cidofovir and Ganciclovir, in Treating Patients With AIDS Who Have CMV Retinitis

HIV Infections | Cytomegalovirus Retinitis

United States
Astra USA

Completed

A Multicenter Study of Oral Versus Intravenous Hydration in AIDS Patients With CMV Retinitis Treated With Foscavir (Foscarnet Sodium)

HIV Infections | Cytomegalovirus Retinitis

United States
Hoffmann-La Roche

Completed

A Randomized Controlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDS

HIV Infections | Cytomegalovirus Retinitis

United States, Canada
Hoffmann-La Roche

Unknown

Valganciclovir in Patients With CMV Retinitis and AIDS Who Cannot Take Drugs by Injection

HIV Infections | Cytomegalovirus Retinitis

United States, Puerto Rico
Roche Global Development

Completed

A Randomized, Controlled Study of the Safety and Preventive Efficacy of Oral Ganciclovir When Used in Conjunction With An Intravitreal Ganciclovir Implant in the Treatment of Cytomegalovirus Retinitis

HIV Infections | Cytomegalovirus Retinitis

United States
Ramazan Gozukucuk

Completed

The Relationship Between CMV* Reactivation and Anti-cytokine Treatment in Critical COVID-19 Patients (Cytomegalovir)

COVID-19, Cytomegalovirus (CMV), Tocilizumab, Anakinra, Mortality

Turkey
Kuifang Du
Beijing Tongren Hospital

Completed

Deep Learning-based System and AIDS-related Cytomegalovirus Retinitis

Cytomegalovirus Retinitis

China
Johns Hopkins Bloomberg School of Public Health
Johns Hopkins University; Memorial Sloan Kettering Cancer Center; Baylor College... and other collaborators

Completed

Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT) (FGCRT)

HIV Infections | Cytomegalovirus Retinitis

Clinical Trials on Cytomegalovirus-Infektionen

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Estonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations